24 May 2013
Keywords: Merck & Co, Fosamax, Damages award, Osteoporosis
Article | 28 June 2010
US drug giant Merck & Co said on Friday that it is challenging the decision returned by a New York ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
28 June 2010
29 June 2010
23 May 2013
© 2013 thepharmaletter.com